Journal of Pediatric Epilepsy 2020; 09(01): 013-017
DOI: 10.1055/s-0039-3400237
Case Report
Georg Thieme Verlag KG Stuttgart · New York

A De Novo KCNQ2 Genomic Variant in an Infant with Early Infantile Epileptic Encephalopathy

1   Department of Neurology, Hospital de Niños Dr. Roberto Gilbert Elizalde, Guayaquil, Ecuador
,
Melissa Coronel
2   School of Medicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador
,
Richard Vaca
2   School of Medicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador
,
Arianna Baquerizo
2   School of Medicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador
,
Rocío Sánchez-Carpintero
3   Pediatric Neurology Unit, Clínica Universidad de Navarra, Pamplona, Spain
› Author Affiliations
Further Information

Publication History

06 February 2019

03 October 2019

Publication Date:
13 November 2019 (online)

Abstract

Early infantile epileptic encephalopathies (EIEEs) constitute a group of severe early onset epilepsies. Although still classified under syndromic clusters of clinical features, the genetic basis of several EIEEs leads to the definition of new types of epilepsies. We report a newborn male with seizures since his second day of life. The results of the first line diagnostic tests did not identify the cause of the seizures, which prompted a genetic study. A de novo KCNQ2 genomic variant that may explain the neonatal epileptic encephalopathy was found and led to more appropriate treatment. Genetic testing allows more specific treatment and more accurate prognosis, and also adds to the database of the phenotypes associated with the genomic variants.

 
  • References

  • 1 Shellhaas RA, Wusthoff CJ, Tsuchida TN. , et al; Neonatal Seizure Registry. Profile of neonatal epilepsies: characteristics of a prospective US cohort. Neurology 2017; 89 (09) 893-899
  • 2 Ortega-Moreno L, Giráldez BG, Soto-Insuga V. , et al; Grupo Español de Genética de las Epilepsias de la Infancia (GEGEI). Molecular diagnosis of patients with epilepsy and developmental delay using a customized panel of epilepsy genes. PLoS One 2017; 12 (11) e0188978
  • 3 Kato M, Yamagata T, Kubota M. , et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia 2013; 54 (07) 1282-1287
  • 4 Weckhuysen S, Ivanovic V, Hendrickx R. , et al; KCNQ2 Study Group. Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients. Neurology 2013; 81 (19) 1697-1703
  • 5 Pisano T, Numis AL, Heavin SB. , et al. Early and effective treatment of KCNQ2 encephalopathy. Epilepsia 2015; 56 (05) 685-691
  • 6 Richards S, Aziz N, Bale S. , et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
  • 7 Lee I-C, Chang T-M, Liang J-S, Li S-Y. KCNQ2 mutations in childhood nonlesional epilepsy: variable phenotypes and a novel mutation in a case series. Mol Genet Genomic Med 2019; 7 (07) e00816
  • 8 Sato K, Arai N, Omori A, Hida A, Kimura A, Takeuchi S. Hyperammonaemia and associated factors in unprovoked convulsive seizures: a cross-sectional study. Seizure 2016; 43: 6-12